KYMIRA embeds bio-responsive infrared technology into apparel that converts UV, visible light and body heat into targeted infrared wavelengths that penetrate about 4cm into muscle tissue. Its core product line targets athlete recovery and performance, and the company sells to clients including American football teams in the US and professional swimmers in the UK. The company plans further expansion into the US market and intends to launch a new range of bio-tracking devices. Henley Business Angels members provided a follow-on private investment alongside a £500k grant made via Henley Business Angels’ Investor Partnership with Innovate UK. KYMIRA was also selected for the fourth cohort of the Comcast SportsTech Accelerator, which it began in March, supporting its US growth trajectory. CEO Timothy Brownstone has indicated the company is exploring broader medical applications of its technology beyond sports.

Total raised

$1M

Funding rounds

2

Latest round

Grant

Latest activity

May 2024